327 related articles for article (PubMed ID: 15199164)
1. Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.
Mikkers H; Nawijn M; Allen J; Brouwers C; Verhoeven E; Jonkers J; Berns A
Mol Cell Biol; 2004 Jul; 24(13):6104-15. PubMed ID: 15199164
[TBL] [Abstract][Full Text] [Related]
2. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
Wingett D; Long A; Kelleher D; Magnuson NS
J Immunol; 1996 Jan; 156(2):549-57. PubMed ID: 8543805
[TBL] [Abstract][Full Text] [Related]
3. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis.
Wang Z; Bhattacharya N; Weaver M; Petersen K; Meyer M; Gapter L; Magnuson NS
J Vet Sci; 2001 Dec; 2(3):167-79. PubMed ID: 12441685
[TBL] [Abstract][Full Text] [Related]
4. Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice.
An N; Kraft AS; Kang Y
J Hematol Oncol; 2013 Jan; 6():12. PubMed ID: 23360755
[TBL] [Abstract][Full Text] [Related]
5. Self-renewal of murine embryonic stem cells is supported by the serine/threonine kinases Pim-1 and Pim-3.
Aksoy I; Sakabedoyan C; Bourillot PY; Malashicheva AB; Mancip J; Knoblauch K; Afanassieff M; Savatier P
Stem Cells; 2007 Dec; 25(12):2996-3004. PubMed ID: 17717068
[TBL] [Abstract][Full Text] [Related]
6. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
7. Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related.
Lilly M; Le T; Holland P; Hendrickson SL
Oncogene; 1992 Apr; 7(4):727-32. PubMed ID: 1314369
[TBL] [Abstract][Full Text] [Related]
8. The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets.
Saurabh K; Scherzer MT; Shah PP; Mims AS; Lockwood WW; Kraft AS; Beverly LJ
Oncotarget; 2014 Sep; 5(18):8503-14. PubMed ID: 25238262
[TBL] [Abstract][Full Text] [Related]
9. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer.
Mikkers H; Allen J; Knipscheer P; Romeijn L; Hart A; Vink E; Berns A
Nat Genet; 2002 Sep; 32(1):153-9. PubMed ID: 12185366
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Pim-1 function in mutant mice.
Domen J; van der Lugt NM; Laird PW; Saris CJ; Berns A
Leukemia; 1993 Aug; 7 Suppl 2():S108-12. PubMed ID: 8361211
[TBL] [Abstract][Full Text] [Related]
11. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway.
Lilly M; Sandholm J; Cooper JJ; Koskinen PJ; Kraft A
Oncogene; 1999 Jul; 18(27):4022-31. PubMed ID: 10435626
[TBL] [Abstract][Full Text] [Related]
12. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
[TBL] [Abstract][Full Text] [Related]
13. Developmental expression of pim kinases suggests functions also outside of the hematopoietic system.
Eichmann A; Yuan L; Bréant C; Alitalo K; Koskinen PJ
Oncogene; 2000 Feb; 19(9):1215-24. PubMed ID: 10713710
[TBL] [Abstract][Full Text] [Related]
14. The Pim kinase pathway contributes to survival signaling in primed CD8+ T cells upon CD27 costimulation.
Peperzak V; Veraar EA; Keller AM; Xiao Y; Borst J
J Immunol; 2010 Dec; 185(11):6670-8. PubMed ID: 21048108
[TBL] [Abstract][Full Text] [Related]
15. The essential role of PIM kinases in sarcoma growth and bone invasion.
Narlik-Grassow M; Blanco-Aparicio C; Cecilia Y; Peregrina S; Garcia-Serelde B; Muñoz-Galvan S; Cañamero M; Carnero A
Carcinogenesis; 2012 Aug; 33(8):1479-86. PubMed ID: 22623646
[TBL] [Abstract][Full Text] [Related]
16. c-Myb regulates the proliferation of immature thymocytes following beta-selection.
Pearson R; Weston K
EMBO J; 2000 Nov; 19(22):6112-20. PubMed ID: 11080157
[TBL] [Abstract][Full Text] [Related]
17. PIM kinases: an overview in tumors and recent advances in pancreatic cancer.
Xu J; Zhang T; Wang T; You L; Zhao Y
Future Oncol; 2014 Apr; 10(5):865-76. PubMed ID: 24799066
[TBL] [Abstract][Full Text] [Related]
18. Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival.
Hammerman PS; Fox CJ; Birnbaum MJ; Thompson CB
Blood; 2005 Jun; 105(11):4477-83. PubMed ID: 15705789
[TBL] [Abstract][Full Text] [Related]
19. The Pim kinases control rapamycin-resistant T cell survival and activation.
Fox CJ; Hammerman PS; Thompson CB
J Exp Med; 2005 Jan; 201(2):259-66. PubMed ID: 15642745
[TBL] [Abstract][Full Text] [Related]
20. Roles of Pim-3, a novel survival kinase, in tumorigenesis.
Mukaida N; Wang YY; Li YY
Cancer Sci; 2011 Aug; 102(8):1437-42. PubMed ID: 21518143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
